Article
O-acetylated Gangliosides as Targets for Cancer Immunotherapy
17 Mar 2020
Abstract excerpt
O-acetylation of sialic acid residues is one of the main modifications of gangliosides, and modulates ganglioside functions. O-acetylation of gangliosides is dependent on sialyl-O-acetyltransferases and sialyl-O-acetyl-esterase activities. CAS1 Domain-Containing Protein 1 (CASD1) is the only human sialyl-O-acetyltransferases (SOAT) described until now. O-acetylated ganglioside species are mainly expressed during...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
